3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Neoplasms
11
Colonic Neoplasms
7
Breast Neoplasms
7
Lung Neoplasms
6
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Respiratory Aspiration
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Postoperative Complications
2
Pituitary Neoplasms
2
Ovarian Neoplasms
2
Neoplastic Cells, Circulating
2
Neoplasm Metastasis
2
Melanoma
2
Uterine Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Recurrence
1
Quality of Recovery
1
Postoperative Cognitive Complications
1
Pain, Postoperative
1
Neurofibromatoses
1
Myofibroma
1
Liver Neoplasms
1
Liver Functions Tests
1
Intraoral Tumor
1
Inflammation
1
Interventions
Paclitaxel
42
Carboplatin
35
pembrolizumab
25
Surveys and Questionnaires
23
Letrozole
15
Radiotherapy
14
Megestrol Acetate
14
Blood Specimen Collection
14
Bevacizumab
13
olaparib
12
Metformin
12
dostarlimab
10
Indocyanine Green
10
durvalumab
9
Observation
9
Medroxyprogesterone Acetate
9
Cisplatin
9
lenvatinib
8
atezolizumab
8
Early Intervention, Educational
8
Counseling
8
niraparib
7
Sentinel Lymph Node Biopsy
7
Radiation
7
Methods
7
Magnetic Resonance Spectroscopy
7
Lymph Node Excision
7
Hysterectomy
7
Everolimus
7
abemaciclib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Endometrial Neoplasms
×
Sevoflurane
×
Clear all
NCT00531349
2016-05-09
ECA/R
The Cleveland Clinic
Phase 3
Withdrawn